Navigation Links
Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company
Date:5/23/2013

ALBUQUERQUE, N.M., May 23, 2013 /PRNewswire/ -- Net Medical Xpress Solutions, Inc., (OTC QB: NMXS), a leader in the telemedicine market, announced today the company has signed a letter of intent to acquire MedTel Solutions, a telemedicine staffing company based in Huntsville, AL. MedTel Solutions is a physician staffing agency that specializes in the staffing and recruitment of telemedicine physicians. Consideration for the acquisition will be announced upon completion of the final agreement, which is expected by June 30, 2013.

Dick Govatski, CEO, Net Medical, said, "We are excited about the additional capabilities our proposed acquisition of MedTel Solutions will bring to our growing array of telemedicine services. The new division will operate as Net Medical Xpress Staffing. This makes Net Medical a one solution company with technology, experience and staffing capabilities to meet any client's needs in the telemedicine environment."  

Jason Sowash , CEO of MedTel Solutions, said, "These are exciting times for MedTel Solutions as we will merge the capabilities of two great telemedicine companies together. This new formation will provide Net Medical access to a national network of physicians. In addition, MedTel will continue to recruit not only primary care physicians, but expand its network to all medical specialties to meet the ever growing demand for physicians in the Telemedicine sector."

With the acquisition, Net Medical will operate four telemedicine units including: Net Medical Xpress Solutions, Inc. providing software development, infrastructure and networking services; Net Medical Xpress Services, a teleradiology diagnostic service; Net Medical Xpress Specialists, a clinical service for hospitals needing neurologists, psychiatrists and cardiologists for telemedicine; and Net Medical Xpress Staffing, providing telemedicine physician recruiting and staffing.

About Net Medical Xpress
Net Medical Xpress is a medical services company that provides clinical and diagnostic programs using advanced telemedicine solutions for hospitals. The company also develops FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments. The company conducted a conference call on May 16, 2013 to discuss its Q1 2013 financial results, business highlights and outlook. An archived webcast of the call, which included Q&A with investors, is available at http://www.hawkassociates.com/profile/nmxs.cfm or http://public.viavid.com/index.php?id=104717. This call will be archived for approximately 90 days.

For more information, visit www.netmedical.com or www.nmxs.com or contact Dick Govatski, president and CEO, at 505-255-1999 or ceo@nmxs.com.

An investment profile on Net Medical Xpress Solutions, Inc. may be found at http://www.hawkassociates.com/profile/nmxs.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

For more investor-related questions contact Frank Hawkins , Hawk Associates, at 305-451-1888 or Dick Govatski at 505-255-1999 (ceo@nmxs.com).

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's Forms 10-K and 10-Q filed with the SEC.


'/>"/>
SOURCE Net Medical Xpress Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... 11, 2017  Caris Life Sciences ® , a ... promise of precision medicine, today announced that St. Jude ... Oncology Alliance™ (POA) as its 17 th member. ... Jude Crosson Cancer Institute will help develop standards of ... tumor profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
Breaking Medicine News(10 mins):